share_log

Estrella Biopharma, Inc. To Become A Publicly Traded Company Via Merger With TradeUP Acquisition Corp.; The Pro Forma Equity Valuation (Assuming No Redemptions) Of The Combined Company Is Expected To Be ~$398.5M

Estrella Biopharma, Inc. To Become A Publicly Traded Company Via Merger With TradeUP Acquisition Corp.; The Pro Forma Equity Valuation (Assuming No Redemptions) Of The Combined Company Is Expected To Be ~$398.5M

Estrella Biopharma, Inc. 将通过与TradeUp Acquisition Corp. 的合并成为一家上市公司;合并后的公司的预计股权估值(假设没有赎回)预计约为3.985亿美元
Benzinga Real-time News ·  2022/10/03 07:31

Estrella Biopharma, Inc. To Become A Publicly Traded Company Via Merger With TradeUP Acquisition Corp.; The Pro Forma Equity Valuation (Assuming No Redemptions) Of The Combined Company Is Expected To Be ~$398.5M

Estrella Biopharma, Inc. 将通过与TradeUp Acquisition Corp. 的合并成为一家上市公司;合并后的公司的预计股权估值(假设没有赎回)预计约为3.985亿美元

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发